MGLL and melanoma: In a pioneering comprehensive investigation [18], shRNA-mediated silencing of MAGL was shown to inhibit migration and invasion of the melanoma cell line C8161 and the ovarian cancer cell line SKOV3, with the migration reduced by shRNA being reversed in both cell lines by treatment with fatty acids.